Atrion Corporation (ATRI) to Release Quarterly Earnings on Wednesday

Atrion Corporation (NASDAQ:ATRI) will be announcing its earnings results after the market closes on Wednesday, November 1st.

Atrion Corporation (NASDAQ:ATRI) last posted its earnings results on Tuesday, August 8th. The medical instruments supplier reported $5.40 earnings per share for the quarter. The firm had revenue of $36.16 million for the quarter. Atrion Corporation had a return on equity of 18.67% and a net margin of 22.75%. On average, analysts expect Atrion Corporation to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Atrion Corporation (ATRI) opened at 652.95 on Tuesday. The firm’s 50-day moving average price is $663.88 and its 200 day moving average price is $609.32. Atrion Corporation has a 12-month low of $426.64 and a 12-month high of $694.00. The company has a market capitalization of $1.21 billion, a price-to-earnings ratio of 36.58 and a beta of 0.92.

In other Atrion Corporation news, Chairman Emile A. Battat sold 1,408 shares of the company’s stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $652.91, for a total transaction of $919,297.28. Following the sale, the chairman now owns 148,881 shares of the company’s stock, valued at $97,205,893.71. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 23.10% of the company’s stock.

WARNING: “Atrion Corporation (ATRI) to Release Quarterly Earnings on Wednesday” was posted by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another site, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this piece can be viewed at https://www.com-unik.info/2017/10/31/atrion-corporation-atri-to-release-quarterly-earnings-on-wednesday.html.

Separately, BidaskClub cut shares of Atrion Corporation from a “strong-buy” rating to a “buy” rating in a research report on Thursday, July 27th.

About Atrion Corporation

Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety.

Earnings History for Atrion Corporation (NASDAQ:ATRI)

What are top analysts saying about Atrion Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Atrion Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit